Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Nebivolol vs Combination in Marfan Syndrome
NCT00683124Phase 3Unknown
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jul 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in Marfan syndrome (MFS), sponsored by IRCCS San Matteo Foundation. Status: unknown.
02
Drugs
nebivolol
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT00683124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683124.